MedTrace Logo

Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma

NCT00863395 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2014-03-31

No results posted yet for this study

Summary

The purpose of this study is to define the mechanisms that underlie the refractory pruritus (itch) in Cutaneous T-Cell Lymphoma (CTCL).

Conditions

  • Cutaneous T-Cell Lymphoma

Interventions

PROCEDURE

skin biopsy

Lidocaine 1% c Epinephrine for local anesthesia

Sponsors & Collaborators

Principal Investigators

  • Maria Hordinsky, MD · University of Minnesota

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00863395 on ClinicalTrials.gov